Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
Neurology
|
January 26, 2006
Interleukin-8 CSF levels predict survival in patients with leptomeningeal metastases
D Brandsma, M J B Taphoorn, W de Jager, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2004
The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study
W Boogerd, M J van den Bent, P J Koehler, et al.
British Journal of Cancer
|
March 1, 2003
Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFN alpha in patients with metastatic melanoma
G C de Gast, D Batchelor, M J Kersten, et al.
The New England Journal of Medicine
|
January 11, 1990
Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer
R G van der Hoop, C J Vecht, M E van der Burg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 22, 2003
Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972
M J van den Bent, O Chinot, W Boogerd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2001
Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients
M Klein, M J Taphoorn, J J Heimans, et al.
Neurology
|
October 22, 1998
Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group
M J van den Bent, J M Kros, J J Heimans, et al.
Psycho-Oncology
|
February 26, 2011
Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study
C M T Schilder, C Seynaeve, S C Linn, et al.
Critical Reviews in Oncology/Hematology
|
December 29, 2009
Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors
C M T Schilder, C Seynaeve, S C Linn, et al.
Neurology
|
November 26, 2009
IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide
H J Dubbink, W Taal, R van Marion, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
Neurology
|
January 26, 2006
Interleukin-8 CSF levels predict survival in patients with leptomeningeal metastases
D Brandsma, M J B Taphoorn, W de Jager, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2004
The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study
W Boogerd, M J van den Bent, P J Koehler, et al.
British Journal of Cancer
|
March 1, 2003
Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFN alpha in patients with metastatic melanoma
G C de Gast, D Batchelor, M J Kersten, et al.
The New England Journal of Medicine
|
January 11, 1990
Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer
R G van der Hoop, C J Vecht, M E van der Burg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 22, 2003
Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972
M J van den Bent, O Chinot, W Boogerd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2001
Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients
M Klein, M J Taphoorn, J J Heimans, et al.
Neurology
|
October 22, 1998
Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group
M J van den Bent, J M Kros, J J Heimans, et al.
Psycho-Oncology
|
February 26, 2011
Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study
C M T Schilder, C Seynaeve, S C Linn, et al.
Critical Reviews in Oncology/Hematology
|
December 29, 2009
Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors
C M T Schilder, C Seynaeve, S C Linn, et al.
Neurology
|
November 26, 2009
IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide
H J Dubbink, W Taal, R van Marion, et al.
Page
of 7